Medical Business & Innovation (MBI) – MSc in Management of Innovation
Students learn to work across disciplines, bridge the worlds of medicine and business, and translate scientific and clinical insights into meaningful and sustainable healthcare innovations. The programme fully aligns with the Convergence ambition to educate the next generation of professionals who can drive change across institutional and disciplinary boundaries.
About the MBI Programme
Who is it for?
The one-year, full-time master is intended for graduates from healthcare or life sciences (e.g. biomedicine, biology, clinical technology, nursing, pharmacology), as well as students from business or innovation programmes who want to innovate in healthcare, medtech or biotech.
-
Why choose MBI?
- Joint expertise from RSM and Erasmus MC
- Interdisciplinary curriculum tailored to healthcare innovation
- Close-knit, collaborative learning community
- Excellent career prospects (75% employed within six months)
Programme details
Start date: September 2026
Duration: 12 months, full-time
Tuition (EEA): €2,695
Application deadline: 15 May 2026
Degree: MSc in Management of Innovation (specialisation MBI)
- Admission requirements
- BSc in healthcare or life sciences
- At least 15 EC in business administration coursework. Missing the required business EC?
- RSM’s online Minor Business Management (15 EC) meets this requirement.
- Minimum GPA: 7.0
- English proficiency at C1 level
Career prospects
Graduates pursue roles such as: R&D Manager • Product Developer • Medtech Entrepreneur • Project Manager • Healthcare Digital Officer in sectors including medtech, biotech, pharmaceuticals and consulting.
👉 Learn more at the MBI session during the Master Open Day on 22 November: eur.nl/masteropenday
👉 More info and application: rsm.nl/mbi